Arbutus Biopharma Corp
NASDAQ:ABUS 3:59:57 PM EDT
| Market Cap (Intraday) | 398.62M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.10 |
| 50-Day MA | $3.89 |
| 200-Day MA | $3.48 |
Arbutus Biopharma Corp Stock, NASDAQ:ABUS
701 Veterans Circle, Suite 100, Warminster, Pennsylvania 18974
Phone: +1.267.469.0914
Number of Employees: 78
Description
Arbutus Biopharma Corp. is a biopharmaceutical company. It engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.